Among infants aged 90 days or younger who present to the emergency department (ED) or hospital with hypothermia, what is the ...
January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
Vietnam Investment Review on MSN
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...
PALOMA study is one of the largest longitudinal studies correlating eye-movement measure with cognitive status in patients with Parkinson’sNEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback